See Remarks
Avg Cost/Share
$12.90
Shares
1,366
Total Value
$17,625.50
Owned After
69,956
SEC Form 4
See Remarks
Avg Cost/Share
$11.99
Shares
2,206
Total Value
$26,454.35
Owned After
69,956
SEC Form 4
President of R&D, Therapeutics
Avg Cost/Share
$25.07
Shares
16,723
Total Value
$419,570.35
Owned After
69,956
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Akinsanya Karen | SDGR | See Remarks | Mar 5, 2026 | Sell | $12.90 | 1,366 | $17,625.50 | 69,956 | |
| Akinsanya Karen | SDGR | See Remarks | Mar 2, 2026 | Sell | $11.99 | 2,206 | $26,454.35 | 69,956 | |
| Akinsanya Karen | SDGR | President of R&D, Therapeutics | Apr 14, 2025 | Sell | $25.07 | 16,723 | $419,570.35 | 69,956 |